Rutgers researcher David Alland, working with the California biotechnology company Cepheid, has received a grant of nearly $640,000 from the National Institutes of Health to develop a rapid test to diagnose Ebola as well ...
Dec 8, 2014
0
0
The World Health Organization voiced hope Tuesday the number of Ebola cases would start falling sharply early next year, stressing the need to develop rapid diagnostic tests for the end-phase.
Nov 18, 2014
0
0
People hospitalised with fever in Africa are most likely to be treated for malaria but, in some areas, nearly all of these patients are ill from a different infection, a new collaborative study led by a University of Otago ...
Jul 19, 2013
0
0
T2 Biosystems, a company developing direct detection products enabling superior diagnostics, today announced the publication of research supporting the Company's flagship diagnostic test, T2Candida, in Science Translational ...
Apr 24, 2013
0
0
